Benzinga Rankings give you vital metrics on any stock – anytime.
Explore Solid Biosciences stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for SLDB.
You can purchase shares of Solid Biosciences (NASDAQ:SLDB) through any online brokerage.
Other companies in Solid Biosciences’s space includes: Humacyte (NASDAQ:HUMA), Monopar Therapeutics (NASDAQ:MNPR), Tevogen Bio Holdings (NASDAQ:TVGN), Anika Therapeutics (NASDAQ:ANIK) and Abeona Therapeutics (NASDAQ:ABEO).
Solid Biosciences has a consensus price target of $15.75.
The stock price for Solid Biosciences (NASDAQ: SLDB) is $2.7 last updated April 14, 2025 at 7:54 PM EDT.
There are no upcoming dividends for Solid Biosciences.
Solid Biosciences’s Q1 earnings are confirmed for Wednesday, May 14, 2025.
There is no upcoming split for Solid Biosciences.
Solid Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.